Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
First Trust Cloud Computing ETF
SKYY
$3.38B
| $633K | ﹤0.01% |
4,702
| – | – |
|
3052
H.B. Fuller
FUL
$2.69B
| $631K | ﹤0.01% |
10,821
-2,077
| -16% | -$128K |
|
|
CNR
3053
Core Natural Resources Inc
CNR
$4.42B
| $630K | ﹤0.01% |
7,879
-17,768
| -69% | -$1.57M |
|
3054
Iovance Biotherapeutics
IOVA
$4.98B
| $629K | ﹤0.01% |
151,112
+87,932
| +139% | +$334K |
|
3055
EyePoint Inc
EYPT
$312M
| $628K | ﹤0.01% |
43,948
+17,789
| +68% | +$238K |
|
3056
Citizens Community Bancorp
CZWI
$206M
| $628K | ﹤0.01% |
26,854
-2,033
| -7% | -$42.6K |
|
|
BIOA
3057
BioAge Labs
BIOA
$324M
| $628K | ﹤0.01% |
25,620
-2,620
| -9% | -$47.3K |
|
3058
Rayonier
RYN
$5.62B
| $628K | ﹤0.01% |
29,491
-60,492
| -67% | -$1.27M |
|
3059
Newmark Group
NMRK
$2.37B
| $628K | ﹤0.01% |
41,533
-59
| -0.1% | -$901 |
|
3060
Cactus
WHD
$4.48B
| $628K | ﹤0.01% |
12,249
-1,131
| -8% | -$63.1K |
|
3061
Invesco NASDAQ 100 ETF
QQQM
$109B
| $627K | ﹤0.01% |
2,068
+257
| +14% | +$72.8K |
|
3062
Red Cat Holdings
RCAT
$1.02B
| $626K | ﹤0.01% |
58,755
+21,094
| +56% | +$243K |
|
3063
John Wiley & Sons Class A
WLY
$2.41B
| $625K | ﹤0.01% |
12,891
-1,826
| -12% | -$76.8K |
|
3064
Diebold Nixdorf
DBD
$2.13B
| $625K | ﹤0.01% |
7,350
+56
| +0.8% | +$4.5K |
|
|
RAPP
3065
Rapport Therapeutics
RAPP
$1.63B
| $625K | ﹤0.01% |
14,994
+5,383
| +56% | +$198K |
|
3066
Zura Bio
ZURA
$387M
| $624K | ﹤0.01% |
105,746
-64,087
| -38% | -$305K |
|
3067
Malibu Boats
MBUU
$474M
| $623K | ﹤0.01% |
22,723
+978
| +4% | +$26K |
|
3068
KVH Industries
KVHI
$134M
| $622K | ﹤0.01% |
62,777
-926
| -1% | -$8.86K |
|
3069
American Express Global Business Travel
GBTG
$4.96B
| $619K | ﹤0.01% |
65,942
-4,882
| -7% | -$39.6K |
|
3070
Urban Edge Properties
UE
$2.51B
| $618K | ﹤0.01% |
27,029
-32,312
| -54% | -$712K |
|
3071
International Seaways
INSW
$5.23B
| $615K | ﹤0.01% |
8,026
+164
| +2% | +$13.3K |
|
3072
Hanmi Financial
HAFC
$952M
| $614K | ﹤0.01% |
18,951
-6,247
| -25% | -$186K |
|
3073
Ecovyst
ECVT
$1.11B
| $613K | ﹤0.01% |
49,205
+9,457
| +24% | +$128K |
|
3074
United States Lime & Minerals
USLM
$3.2B
| $612K | ﹤0.01% |
5,843
-3,818
| -40% | -$443K |
|
3075
Ingevity
NGVT
$2.51B
| $611K | ﹤0.01% |
8,186
-1,038
| -11% | -$74.7K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.